TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28017403

Group type: EXPERIMENTAL
Intervention: Immediate vaccination with rVSV-ZEBOV (2×10^7 plaque-forming units administered intramuscularly)
Number of subjects: 5837

Group type: COMPARATOR
Intervention: Delayed vaccination (21 days after randomisation)
Number of subjects: 5837

Group type: EXPERIMENTAL
Intervention: Immediate vaccination in non-randomised clusters
Number of subjects: 5837

Group type: COMPARATOR
Intervention: Delayed vaccination plus all eligible contacts and contacts of contacts never vaccinated in immediate clusters
Number of subjects: 5837

Group type: EXPERIMENTAL
Intervention: Immediate vaccination
Number of subjects: 5837
Study: 28039296

Group type: EXPERIMENTAL
Intervention: Senior Dance plus brief education for falls prevention
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group receiving only brief education
Number of subjects: 82
Study: 24149855

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) combined with dynamic fascial sutures (DFS)
Number of subjects: 87
Study: 23085185

Group type: EXPERIMENTAL
Intervention: Imagining a vulnerable individual (e.g., elderly man)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Imagining an able-bodied individual (e.g., strong youthful male)
Number of subjects: 66
Study: 20027347

Group type: EXPERIMENTAL
Intervention: Anaferon (pediatric formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 17342417

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg for 8 weeks and atorvastatin 80 mg for the final 8 weeks (aggressive treatment)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Simvastatin 40 mg (conventional treatment)
Number of subjects: 100
Study: 14693617

Group type: EXPERIMENTAL
Intervention: Pancuronium
Number of subjects: 70

Group type: COMPARATOR
Intervention: Rocuronium
Number of subjects: 70
Study: 11586013

Group type: EXPERIMENTAL
Intervention: Vitamin B(12) cream containing avocado oil
Number of subjects: 13

Group type: COMPARATOR
Intervention: Calcipotriol
Number of subjects: 13
Study: 9479684

Group type: EXPERIMENTAL
Intervention: PTSD group (n = 20)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Non-PTSD group (n = 15)
Number of subjects: 35
Study: 8113063

Group type: EXPERIMENTAL
Intervention: Eat Smart School Nutrition Program (food service intervention)
Number of subjects: 0
Study: 3364148

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with plain bupivacaine 0.5%
Number of subjects: 19

Group type: COMPARATOR
Intervention: Spinal anesthesia with bupivacaine 0.5% in glucose 8%
Number of subjects: 19
Study: 30581236

Group type: EXPERIMENTAL
Intervention: Nitric Oxide (NO) added to the gas phase of the extracorporeal circuit during cardiopulmonary bypass
Number of subjects: 198
Study: 28539168

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation (ONS) in the form of two bottles a day of β‐hydroxy‐β‐methylbutyrate (HMB)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Standard diet plus ONS (IG)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Standard diet only (CG)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: ONS
Number of subjects: 107
Study: 25577032

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES) infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 40
Study: 23468196

Group type: EXPERIMENTAL
Intervention: 9.5‐mm ultrathin colonoscope (UTC)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Standard colonoscope
Number of subjects: 203
Study: 21238659

Group type: EXPERIMENTAL
Intervention: Minimal mobilization (MIN)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Complete esophageal dissection (MAX)
Number of subjects: 177
Study: 19108790

Group type: EXPERIMENTAL
Intervention: Propofol 0.5 mg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Droperidol 20 microg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.2 mg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 100
Study: 15982632

Group type: EXPERIMENTAL
Intervention: Feedback to supervisors
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Feedback to workgroups
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Feedback to individuals
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 12665145

Group type: EXPERIMENTAL
Intervention: Carprofen
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Meloxicam
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Nutraceutical
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo Control
Number of subjects: 71
Study: 14986633

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9553904

Group type: EXPERIMENTAL
Intervention: Three-year tobacco prevention curriculum (five 45-minute lessons per year)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no tobacco prevention curriculum)
Number of subjects: 8
Study: 7800186

Group type: EXPERIMENTAL
Intervention: Midazolam (0.03 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diazepam (0.1 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 40
Study: 3287999

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation with intramuscular papaveretum
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intramuscular papaveretum alone
Number of subjects: 40
Study: 31523014

Group type: EXPERIMENTAL
Intervention: Community health worker-based intervention with behavioral change communication through regular home visits.
Number of subjects: 1242

Group type: COMPARATOR
Intervention: Usual care in the community (Control group).
Number of subjects: 1242
Study: 29135664

Group type: EXPERIMENTAL
Intervention: Step 1 (acetaminophen)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Step 2 (acetaminophen and tramadol)
Number of subjects: 52
Study: 25932999

Group type: EXPERIMENTAL
Intervention: Old RBC transfusion (>15 days storage)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fresh RBC transfusion (<10 days storage)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Old and Fresh RBC transfusion)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Old RBC transfusion
Number of subjects: 20
Study: 22658588

Group type: EXPERIMENTAL
Intervention: C(1h) - 6 mg kg(‐1) caffeine consumed 1 hour prior to exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: C(peak) - 6 mg kg(‐1) caffeine consumed at peak serum concentration
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 21742583

Group type: EXPERIMENTAL
Intervention: Extended-release formulation of ciprofloxacin (500 mg once daily)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Immediate-release formulation of ciprofloxacin (250 mg twice daily)
Number of subjects: 36
Study: 18728933

Group type: EXPERIMENTAL
Intervention: Dihydralazine 3.125 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dihydralazine 6.250 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dihydralazine 9.375 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 16685123

Group type: EXPERIMENTAL
Intervention: Rigorous glycaemic control (RC) with i.v. insulin and intravenous crystalloid
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard management (SM) with intravenous crystalloid
Number of subjects: 25
Study: 15300734

Group type: EXPERIMENTAL
Intervention: MF-on (50 Hz magnetic field)
Number of subjects: 15

Group type: COMPARATOR
Intervention: MF-off (control)
Number of subjects: 15
Study: 11750293

Group type: COMPARATOR
Intervention: Standard outpatient clinic treatment
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Initial level of depression, disability, pain, beliefs about the consequences of arthritis, coping strategies
Number of subjects: 22
Study: 9155828

Group type: EXPERIMENTAL
Intervention: Indomethacin treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 10
Study: 8292466

Group type: EXPERIMENTAL
Intervention: Amlodipine (mean final dose 6.8 mg/day)
Number of subjects: 4621

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 4621
Study: 30660609

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (Nivolumab 3 mg/kg every 2 weeks + Ipilimumab 1 mg/kg every 6 weeks)
Number of subjects: 125
Study: 28862315

Group type: EXPERIMENTAL
Intervention: 12-month progressive home-based training with regular booster sessions (exercise group, n=48)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Usual care (single session of physiotherapy instruction, usual care group, n=50)
Number of subjects: 98
Study: 25980706

Group type: EXPERIMENTAL
Intervention: Virtual Cardiac Rehabilitation Program (vCRP)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 78
Study: 23208876

Group type: EXPERIMENTAL
Intervention: One mass azithromycin distribution
Number of subjects: 24

Group type: COMPARATOR
Intervention: Two mass azithromycin distributions
Number of subjects: 24
Study: 21663652

Group type: EXPERIMENTAL
Intervention: CBPR walking intervention with social support walking groups, pedometer diary self-monitoring, monthly diet and physical activity education sessions, and individualized motivational interviewing sessions.
Number of subjects: 269
Study: 18761593

Group type: EXPERIMENTAL
Intervention: Immediate circumcision
Number of subjects: 2784

Group type: COMPARATOR
Intervention: Delayed circumcision (control group)
Number of subjects: 2784
Study: 16390567

Group type: COMPARATOR
Intervention: Intravenous saline 0.9% (Group I, n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 30 mg kg(‐1) bolus + 10 mg kg(‐1) h(‐1) continuous infusion (Group II, n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 50 mg kg(‐1) bolus + 10 mg kg(‐1) h(‐1) continuous infusion (Group III, n = 20)
Number of subjects: 60
Study: 14618196

Group type: EXPERIMENTAL
Intervention: Iloprost infusion (0.5 to 2 ng/kg/min over 6 hours)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 16
Study: 10831007

Group type: EXPERIMENTAL
Intervention: MDI (1.0 mg inhaled flunisolide)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MDI-S (1.0 mg inhaled flunisolide with a spacer device)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral administration (1.0 mg of flunisolide with 240 mL of water)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravenous (1.0 mg flunisolide by IV push)
Number of subjects: 24
Study: 9238407

Group type: EXPERIMENTAL
Intervention: Cornell voltage duration product adjusted for body mass index and age
Number of subjects: 3351

Group type: COMPARATOR
Intervention: Original ECG LVH criteria
Number of subjects: 3351

Group type: EXPERIMENTAL
Intervention: Adjustment algorithms for lean versus obese and normotensive versus hypertensive
Number of subjects: 3351
Study: 1425884

Group type: EXPERIMENTAL
Intervention: Nicardipine SR 40 mg b.i.d. for 3 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nicardipine 20 mg (acute treatment)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Chronic treatment with Nicardipine SR
Number of subjects: 18
Study: 6484101

Group type: EXPERIMENTAL
Intervention: Type A/cardiac counseling
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Cardiac counseling alone
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Nonrandom comparison section
Number of subjects: 1012
Study: 31354158

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (low-dose)
Number of subjects: 3884

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) alone
Number of subjects: 3884
Study: 29590422

Group type: EXPERIMENTAL
Intervention: Non-pharmacologic approaches for pain management (e.g., tai chi)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Communication with provider about complementary approaches
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Care coordination
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Veteran expectations about pain experience
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Veteran knowledge and beliefs about complementary approaches
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Access to non-pharmacologic treatments
Number of subjects: 36
Study: 26946728

Group type: EXPERIMENTAL
Intervention: Mild moxibustion
Number of subjects: 60

Group type: COMPARATOR
Intervention: TDP
Number of subjects: 60
Study: 25083928

Group type: EXPERIMENTAL
Intervention: Anodal tDCS at 1 mA for 15 minutes
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS at 1 mA for 15 minutes
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 16
Study: 23265076

Group type: EXPERIMENTAL
Intervention: Group diabetes education programme (4 sessions delivered by a health promotion officer)
Number of subjects: 1570

Group type: COMPARATOR
Intervention: Usual care (ad hoc advice during consultations and occasional educational talks)
Number of subjects: 1570

Group type: EXPERIMENTAL
Intervention: Group diabetes education programme
Number of subjects: 1570

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1570
Study: 20301996

Group type: EXPERIMENTAL
Intervention: Continuous infusion of vancomycin (15 mg/kg loading dose for 1 h followed by 30 mg/kg continuous infusion over 24 h for 48 h)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intermittent infusion of vancomycin (15 mg/kg for 1 h every 12 h for 48 h)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both continuous and intermittent infusion of vancomycin
Number of subjects: 12
Study: 18416216

Group type: EXPERIMENTAL
Intervention: Reduced prime extracorporeal circuit and vacuum‐assisted venous drainage (VAVD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard CPB with full prime volume (control group)
Number of subjects: 40
Study: 14691416

Group type: EXPERIMENTAL
Intervention: Private transportation
Number of subjects: 2388

Group type: COMPARATOR
Intervention: Calling 9-1-1 (EMS)
Number of subjects: 2388

Group type: EXPERIMENTAL
Intervention: EMS
Number of subjects: 2388

Group type: EXPERIMENTAL
Intervention: Decision to seek care to thrombolytic therapy (EMS)
Number of subjects: 2388
Study: 12530751

Group type: EXPERIMENTAL
Intervention: Euclidean regression analyses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative hypothesis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Null hypothesis
Number of subjects: 0
Study: 9844218

Group type: COMPARATOR
Intervention: TN‐PAP‐ (29 subjects)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TN‐PAP+ (25 subjects)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TN+ PAP‐ (21 subjects)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TN+ PAP+ (25 subjects)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nasal packing
Number of subjects: 100
Study: 7978185

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 50
Study: 2554440

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 8 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate 12 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 5354874

Group type: EXPERIMENTAL
Intervention: Decreased intestinal absorption of calcium; possible alteration in renal tubular handling of calcium.
Number of subjects: 6
Study: 30977845

Group type: EXPERIMENTAL
Intervention: Gardasil-9 (licensed prophylactic HPV vaccine)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Gardasil-9
Number of subjects: 345
Study: 28937021

Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg plus amoxicillin 750 mg (4 times/day for 14 days)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg plus amoxicillin 750 mg (4 times/day for 14 days)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Bismuth-containing quadruple regimen (rabeprazole 20 mg, bismuth 220 mg, amoxicillin 1000 mg, clarithromycin 500 mg, 2 times/day for 14 days)
Number of subjects: 263
Study: 26031566

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 637

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 637
Study: 23770332

Group type: EXPERIMENTAL
Intervention: Intradermal fractional-dose IPV (ID-JI-0.1)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Full-dose intramuscular needle (IM-NS-0.5)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Full-dose intramuscular jet injector (IM-JI-0.5)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Fractional-dose intramuscular needle (IM-NS-0.1)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Intradermal jet injector (ID-JI-0.1)
Number of subjects: 125
Study: 21991951

Group type: EXPERIMENTAL
Intervention: 7 mg of teriflunomide
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: 14 mg of teriflunomide
Number of subjects: 1088

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1088
Study: 18774344

Group type: EXPERIMENTAL
Intervention: Unrestricted stop rule during ischemic pain task
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Tolerance stop rule during ischemic pain task
Number of subjects: 61
Study: 16930383

Group type: EXPERIMENTAL
Intervention: Two-year universal classroom-based intervention targeting disruptive behavior
Number of subjects: 508

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 508
Study: 14600055

Group type: EXPERIMENTAL
Intervention: Adherence coaching
Number of subjects: 286

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 286

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 286
Study: 11076315

Group type: EXPERIMENTAL
Intervention: Electromechanically guided percutaneous transluminal myocardial laser revascularization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoroscopically guided percutaneous transluminal myocardial laser revascularization
Number of subjects: 0
Study: 8927880

Group type: EXPERIMENTAL
Intervention: 20 mg retarded nifedipine + 25 mg atenolol
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 20 mg retarded nifedipine + 50 mg atenolol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 1433548

Group type: EXPERIMENTAL
Intervention: Percutaneous embolization
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: High ligation of the internal spermatic vein
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Transinguinal simultaneous ligation of the internal and external spermatic veins
Number of subjects: 119
Study: 4013826

Group type: EXPERIMENTAL
Intervention: Sandfly fever virus inoculation
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sterile saline (control)
Number of subjects: 9
Study: 31690089

Group type: EXPERIMENTAL
Intervention: Guided Internet‐based self‐help cognitive behavioral intervention
Number of subjects: 188

Group type: COMPARATOR
Intervention: Attention‐only control group
Number of subjects: 188
Study: 30887592

Group type: EXPERIMENTAL
Intervention: Bubble breath exercise
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 66
Study: 28489506

Group type: EXPERIMENTAL
Intervention: Prehospital intubation
Number of subjects: 882

Group type: COMPARATOR
Intervention: Air transport
Number of subjects: 882
Study: 23846682

Group type: EXPERIMENTAL
Intervention: SLNB
Number of subjects: 194

Group type: COMPARATOR
Intervention: No SLNB
Number of subjects: 194
Study: 23826914

Group type: EXPERIMENTAL
Intervention: Polaprezinc (150 mg/day for 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no polaprezinc treatment)
Number of subjects: 20
Study: 21739372

Group type: EXPERIMENTAL
Intervention: Emodepside/toltrazuril suspension (at least 0.45 mg emodepside plus 9 mg toltrazuril per kg body weight)
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Emodepside/toltrazuril suspension
Number of subjects: 403

Group type: COMPARATOR
Intervention: Reference product (milbemycin oxime plus praziquantel or sulfadimethoxine)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 403
Study: 20396715

Group type: EXPERIMENTAL
Intervention: Artrofoon treatment
Number of subjects: 0
Study: 18163058

Group type: EXPERIMENTAL
Intervention: Antioxidant therapy
Number of subjects: 46
Study: 15195037

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Direct mail recruitment method
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Radio advertisements recruitment method
Number of subjects: 39
Study: 11471578

Group type: EXPERIMENTAL
Intervention: Acupuncture (6 sessions, each lasting up to 25 minutes)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Advice and exercises
Number of subjects: 32

Group type: COMPARATOR
Intervention: Acupuncture vs Advice and exercises
Number of subjects: 32
Study: 9649558

Group type: EXPERIMENTAL
Intervention: Vitamin C (Vit-C) supplementation with GTN
Number of subjects: 9

Group type: COMPARATOR
Intervention: Glyceroltrinitrate (GTN)
Number of subjects: 9
Study: 7925509

Group type: EXPERIMENTAL
Intervention: Anistreplase 30 units i.v. at home (early group)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Anistreplase 30 units i.v. in hospital (late group)
Number of subjects: 311
Study: 2805811

Group type: EXPERIMENTAL
Intervention: Sulconazole nitrate 1 percent cream applied once daily
Number of subjects: 117

Group type: COMPARATOR
Intervention: Clotrimazole applied twice daily
Number of subjects: 117
Study: 171574

Group type: EXPERIMENTAL
Intervention: Halofenate
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sulfonylurea and halofenate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Clofibate
Number of subjects: 12
Study: 31164288

Group type: EXPERIMENTAL
Intervention: Community-based pulmonary rehabilitation (PR) for 3 weeks plus standard medication
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard medication
Number of subjects: 23
Study: 30314830

Group type: EXPERIMENTAL
Intervention: Online decision aid (DA) during counseling
Number of subjects: 382

Group type: COMPARATOR
Intervention: Care-as-usual (control)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Both DA and control groups
Number of subjects: 382